CN112843200A - A Chinese medicinal composition for treating prostatitis and its preparation method - Google Patents
A Chinese medicinal composition for treating prostatitis and its preparation method Download PDFInfo
- Publication number
- CN112843200A CN112843200A CN201911195286.2A CN201911195286A CN112843200A CN 112843200 A CN112843200 A CN 112843200A CN 201911195286 A CN201911195286 A CN 201911195286A CN 112843200 A CN112843200 A CN 112843200A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- dandelion
- dahuoxue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating prostatitis diseases and a preparation method thereof, wherein the composition comprises the following components in parts by weight: 10-15 parts of dandelion, 10-15 parts of herba patriniae, 10-15 parts of Dahuoxue blood, 5-10 parts of rhizoma sparganii, 5-10 parts of curcuma zedoary, 10-15 parts of salvia miltiorrhiza, 10-15 parts of oldenlandia diffusa and 5-10 parts of corydalis tuber; the preparation method comprises the following steps: the components are mixed according to the proportion and prepared into decoction for rectal retention enema administration. The invention has the characteristics of clearing away heat and toxic material, promoting blood circulation by removing blood stasis, diminishing inflammation and relieving pain, and is suitable for treating various prostatitis diseases.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating prostatitis diseases and a preparation method thereof.
Background
Prostate diseases are common diseases of adult men, and generally refer to prostatitis, prostatic hyperplasia, prostate cancer and the like. Prostate disorders may be manifested as frequent urination, urgency, pain, hematuria, dysuria, incontinence, bifurcations in the urinary tract, dribbling after urination, increased frequency of nocturia, and whitish drip after urination or after defecation. And can be used for treating sexual dysfunction, such as hyposexuality, premature ejaculation, ejaculation pain, erection weakness, and sexual impotence. Even secondary upper urinary tract damage, systemic symptoms and the like.
Prostate diseases need different treatment methods according to different causes. Chronic prostatitis usually is mainly treated by comprehensive treatment such as medicine, physical therapy and the like. At present, a plurality of medicines for treating prostatitis diseases are available in the market, and western medicines are mainly used, so that the traditional Chinese medicine preparation has poor effect. The healing effect cannot be achieved. After years of clinical application and observation, the medicines have one or two effects of resisting inflammation, promoting blood circulation, relieving pain, clearing heat and removing toxicity and the like, but cannot simultaneously have all the treatment effects, so that the treatment effect is not good enough.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a traditional Chinese medicine composition for treating prostatitis diseases and a preparation method thereof.
The technical scheme adopted by the invention is as follows:
a traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 10-15 parts of dandelion, 10-15 parts of herba patriniae, 10-15 parts of Dahuoxue blood, 5-10 parts of rhizoma sparganii, 5-10 parts of curcuma zedoary, 10-15 parts of salvia miltiorrhiza, 10-15 parts of oldenlandia diffusa and 5-10 parts of corydalis tuber.
Wherein, the dandelion is sweet, slightly bitter and cold in nature; has the effects of clearing away heat and toxic materials, relieving swelling, and dispersing pathogenic accumulation; herba Patriniae is pungent and slightly cold, and has effects of clearing heat and detoxicating, eliminating phlegm and discharging pus; caulis Sargentodoxae has effects of dredging meridian passage, inducing diuresis for treating stranguria, dispelling blood stasis and relieving pain; the rhizoma sparganii is pungent, bitter and mild in nature, and has the effects of breaking blood, promoting qi circulation, removing food retention, relieving pain and the like; the zedoary is pungent, bitter and warm in nature, and has the effects of removing blood stasis, relieving pain and the like; the salvia miltiorrhiza is bitter in taste and slightly cold, has the effects of activating blood circulation to dissipate blood stasis, stimulating the menstrual flow, relieving pain and the like, and the oldenlandia: bitter and bland in taste and cold in nature. Has effects in clearing away heat and toxic materials, relieving pain, dispersing pathogen accumulation, promoting urination, and removing dampness; rhizoma corydalis: pungent, bitter, warm, nontoxic, and blood circulation promoting; has effects of removing blood stasis, regulating qi-flowing, and relieving pain.
Further, the traditional Chinese medicine composition for treating prostatitis comprises the following components in parts by weight: 5 parts of dandelion, 5 parts of herba patriniae, 5 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 5 parts of salvia miltiorrhiza, 5 parts of oldenlandia diffusa and 5 parts of corydalis tuber.
Further, the traditional Chinese medicine composition for treating prostatitis comprises the following components in parts by weight: 10 parts of dandelion, 10 parts of herba patriniae, 10 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 10 parts of salvia miltiorrhiza, 10 parts of spreading hedyotis herb and 5 parts of corydalis tuber.
Further, the traditional Chinese medicine composition for treating prostatitis comprises the following components in parts by weight: 15 parts of dandelion, 15 parts of herba patriniae, 15 parts of Dahuoxue, 10 parts of rhizoma sparganii, 10 parts of curcuma zedoary, 15 parts of salvia miltiorrhiza, 15 parts of spreading hedyotis herb and 10 parts of corydalis tuber.
Further, the traditional Chinese medicine composition for treating prostatitis comprises the following components in parts by weight: 14 parts of dandelion, 14 parts of herba patriniae, 14 parts of Dahuoxue, 8 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 12 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 8 parts of corydalis tuber.
Further, the traditional Chinese medicine composition for treating prostatitis comprises the following components in parts by weight: 13 parts of dandelion, 13 parts of herba patriniae, 13 parts of Dahuoxue, 7 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 11 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 7 parts of corydalis tuber.
Furthermore, the dosage form of the traditional Chinese medicine composition is decoction administered by rectal retention enema.
A Chinese medicinal composition for treating prostatitis is prepared by mixing the above materials at a certain proportion and making into decoction for rectal retention enema.
The invention has the beneficial effects that: the invention relates to a traditional Chinese medicine composition for treating prostatitis diseases and a preparation method thereof, which is prepared by heat clearing and detoxifying dandelion, dahurian patrinia herb and spreading hedyotis herb; the salvia miltiorrhiza, the sargentgloryvine stem and the corydalis tuber have the effects of dredging the channels, activating blood, regulating qi, removing blood stasis and relieving pain; thereby simultaneously playing the roles of clearing away heat and toxic material, promoting blood circulation by removing blood stasis, diminishing inflammation and relieving pain; but also breaks blood and promotes qi circulation, removes food retention and removes stasis through the rhizoma sparganii and the curcuma zedoary; herba Taraxaci and herba Hedyotidis Diffusae have effects of eliminating phlegm, expelling pus, relieving pain, resolving hard mass, promoting urination and removing dampness; thereby eliminating symptoms such as frequent micturition, urgent micturition, odynuria, hematuria, dysuria, urinary incontinence, bifurcations of urinary line, dribbling after urination, etc.; therefore, the traditional Chinese medicine composition has the characteristics of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, diminishing inflammation and relieving pain, and is suitable for treating various prostatitis diseases.
Detailed Description
The invention is further illustrated by the following specific examples.
A Chinese medicinal composition
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 10-15 parts of dandelion, 10-15 parts of herba patriniae, 10-15 parts of Dahuoxue blood, 5-10 parts of rhizoma sparganii, 5-10 parts of curcuma zedoary, 10-15 parts of salvia miltiorrhiza, 10-15 parts of oldenlandia diffusa and 5-10 parts of corydalis tuber.
Further, the optimized composition is as follows:
a traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 5 parts of dandelion, 5 parts of herba patriniae, 5 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 5 parts of salvia miltiorrhiza, 5 parts of oldenlandia diffusa and 5 parts of corydalis tuber.
Second, preparation method
The composition is prepared into decoction for rectal retention enema administration.
The components are mixed according to the preparation method and prepared into decoction for rectal retention enema administration.
Three, functional indications
Is suitable for treating various prostatitis diseases.
Fourth, example
Example 1
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 12 parts of dandelion, 12 parts of dahurian patrinia herb, 12 parts of Dahuoxue blood, 6 parts of common burreed rhizome, 6 parts of zedoary, 12 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 8 parts of corydalis tuber.
The dosage form of the traditional Chinese medicine composition is decoction administered by rectal retention enema.
Example 2
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 11 parts of dandelion, 11 parts of herba patriniae, 11 parts of Dahuoxue, 7 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 11 parts of salvia miltiorrhiza, 13 parts of spreading hedyotis herb and 7 parts of corydalis tuber.
The dosage form of the traditional Chinese medicine composition is decoction administered by rectal retention enema.
Example 3
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 13 parts of dandelion, 13 parts of herba patriniae, 13 parts of Dahuoxue, 7 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 11 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 7 parts of corydalis tuber.
The components are mixed according to the proportion and prepared into decoction for rectal retention enema administration.
Example 4
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 5 parts of dandelion, 5 parts of herba patriniae, 5 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 5 parts of salvia miltiorrhiza, 5 parts of oldenlandia diffusa and 5 parts of corydalis tuber.
The components are mixed according to the proportion and prepared into decoction for rectal retention enema administration.
Example 5
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 10 parts of dandelion, 10 parts of herba patriniae, 10 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 10 parts of salvia miltiorrhiza, 10 parts of spreading hedyotis herb and 5 parts of corydalis tuber.
The components are mixed according to the proportion and prepared into decoction for rectal retention enema administration.
Example 6
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 15 parts of dandelion, 15 parts of herba patriniae, 15 parts of Dahuoxue, 10 parts of rhizoma sparganii, 10 parts of curcuma zedoary, 15 parts of salvia miltiorrhiza, 15 parts of spreading hedyotis herb and 10 parts of corydalis tuber.
The components are mixed according to the proportion and prepared into decoction for rectal retention enema administration.
Example 7
A traditional Chinese medicine composition for treating prostatitis diseases comprises the following components in parts by weight: 14 parts of dandelion, 14 parts of herba patriniae, 14 parts of Dahuoxue, 8 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 12 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 8 parts of corydalis tuber.
The components are mixed according to the proportion and prepared into decoction for rectal retention enema administration.
Fifth, clinical conditions
The invention relates to a prostatitis treating prescription obtained from a great-exterior grandfather proved prescription in the generation traditional Chinese medicine of inventor families, which is obtained by improvement and has excellent effect in clinical verification.
The formula of the invention can treat 10000 patients with prostatitis, from 2015 to now, 1762 patients are treated, the span of the age range of the patients is large, the patients are all aged 19-55 years, 665 patients with urinary tract irritation such as frequent micturition, urgent micturition and incomplete urine account for 38% of the total patients, and 23% and 20% of the total patients respectively are premature ejaculation and erectile dysfunction patients.
The therapeutic effect criteria are as follows:
firstly, clinical cure: 1. the number of white blood cells is less than 10 per high power of under-mirror visual field during prostate fluid examination; 2. the pain of the prostate massage disappears; 3. clinical symptoms disappeared. Secondly, the treatment is effective: 1. the leucocyte of the prostate fluid is reduced compared with the primary diagnosis; 2. the pain of the prostate massage is relieved; 3. the clinical symptoms are reduced; thirdly, the treatment is ineffective: 1. the number of leucocytes in the prostatic fluid is not reduced compared with that in the initial diagnosis; 2. the pain of the prostate massage is not relieved; 3. no change in clinical symptoms.
1762 patients with increased prostate fluid leukocytes 1638 patients with no symptoms after treatment 1479 patients with a cure rate of 90%; the normal range of the white blood cells is 63 cases, the symptoms disappear in 58 cases, and the cure rate is 92%; 632 patients with prostatic hyperplasia and hyperplasia, 472 patients with prostatic hyperplasia and hyperplasia after treatment, 75% of cure rate, 136 patients with prostatic reduction but no normal range, and 22% of remission rate.
The traditional Chinese medicine is administrated in a rectal retention enema administration mode, so that the temperature of the traditional Chinese medicine is 42 ℃ when the traditional Chinese medicine is subjected to retention enema, a certain heat treatment effect is realized on prostate, the regression of prostatitis is facilitated, 2-6 small hemorrhoid reproduction veins are arranged between a rectal vein and a bladder prostate vein plexus, and the medicine absorbed through the rectum can directly enter prostate tissues through the hemorrhoid reproduction veins, so that the first pass effect of a liver and gastrointestinal tract reaction are avoided.
The present invention is not limited to the above-described alternative embodiments, and various other forms of products can be obtained by anyone in light of the present invention. The above detailed description should not be taken as limiting the scope of the invention, which is defined in the claims, and which the description is intended to be interpreted accordingly.
Claims (8)
1. A traditional Chinese medicine composition for treating prostatitis diseases is characterized in that: the composition comprises the following components in parts by weight: 10-15 parts of dandelion, 10-15 parts of herba patriniae, 10-15 parts of Dahuoxue blood, 5-10 parts of rhizoma sparganii, 5-10 parts of curcuma zedoary, 10-15 parts of salvia miltiorrhiza, 10-15 parts of oldenlandia diffusa and 5-10 parts of corydalis tuber.
2. The traditional Chinese medicine composition for treating prostatitis according to claim 1, which is characterized in that: the composition comprises the following components in parts by weight: 5 parts of dandelion, 5 parts of herba patriniae, 5 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 5 parts of salvia miltiorrhiza, 5 parts of oldenlandia diffusa and 5 parts of corydalis tuber.
3. The traditional Chinese medicine composition for treating prostatitis according to claim 1, which is characterized in that: the composition comprises the following components in parts by weight: 10 parts of dandelion, 10 parts of herba patriniae, 10 parts of Dahuoxue, 5 parts of rhizoma sparganii, 5 parts of curcuma zedoary, 10 parts of salvia miltiorrhiza, 10 parts of spreading hedyotis herb and 5 parts of corydalis tuber.
4. The traditional Chinese medicine composition for treating prostatitis according to claim 1, which is characterized in that: the composition comprises the following components in parts by weight: 15 parts of dandelion, 15 parts of herba patriniae, 15 parts of Dahuoxue, 10 parts of rhizoma sparganii, 10 parts of curcuma zedoary, 15 parts of salvia miltiorrhiza, 15 parts of spreading hedyotis herb and 10 parts of corydalis tuber.
5. The traditional Chinese medicine composition for treating prostatitis according to claim 1, which is characterized in that: the composition comprises the following components in parts by weight: 14 parts of dandelion, 14 parts of herba patriniae, 14 parts of Dahuoxue, 8 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 12 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 8 parts of corydalis tuber.
6. The traditional Chinese medicine composition for treating prostatitis according to claim 1, which is characterized in that: the composition comprises the following components in parts by weight: 13 parts of dandelion, 13 parts of herba patriniae, 13 parts of Dahuoxue, 7 parts of rhizoma sparganii, 7 parts of curcuma zedoary, 11 parts of salvia miltiorrhiza, 12 parts of spreading hedyotis herb and 7 parts of corydalis tuber.
7. The Chinese medicinal composition for treating prostatitis according to any one of claims 1 to 6, wherein the Chinese medicinal composition comprises the following raw materials: the dosage form of the traditional Chinese medicine composition is decoction administered by rectal retention enema.
8. A method for preparing the Chinese medicinal composition for treating prostatitis according to any one of claims 1 to 6, which comprises the following steps: the components are mixed according to the proportion and prepared into decoction for rectal retention enema administration.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911195286.2A CN112843200A (en) | 2019-11-28 | 2019-11-28 | A Chinese medicinal composition for treating prostatitis and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911195286.2A CN112843200A (en) | 2019-11-28 | 2019-11-28 | A Chinese medicinal composition for treating prostatitis and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112843200A true CN112843200A (en) | 2021-05-28 |
Family
ID=75995902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911195286.2A Pending CN112843200A (en) | 2019-11-28 | 2019-11-28 | A Chinese medicinal composition for treating prostatitis and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112843200A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115671244A (en) * | 2022-12-02 | 2023-02-03 | 吴智勇 | A Chinese medicinal composition for treating prostatitis and its preparation method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1478500A (en) * | 2002-08-28 | 2004-03-03 | 张安学 | Adhesive plaster for treating prostatitis |
| CN101125186A (en) * | 2006-09-11 | 2008-02-20 | 蔡胜华 | Chinese medicine for treating prostatitis |
| CN103463582A (en) * | 2013-10-11 | 2013-12-25 | 成都中医药大学 | Medicinal composition for treating pelvic inflammation, as well as preparation and application thereof |
-
2019
- 2019-11-28 CN CN201911195286.2A patent/CN112843200A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1478500A (en) * | 2002-08-28 | 2004-03-03 | 张安学 | Adhesive plaster for treating prostatitis |
| CN101125186A (en) * | 2006-09-11 | 2008-02-20 | 蔡胜华 | Chinese medicine for treating prostatitis |
| CN103463582A (en) * | 2013-10-11 | 2013-12-25 | 成都中医药大学 | Medicinal composition for treating pelvic inflammation, as well as preparation and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 江先汉等: "慢性非细菌性前列腺炎大鼠中药灌肠治疗的作用机制", 《现代医药卫生》 * |
| 黄向阳等: "鲍严钟治疗慢性前列腺炎方法", 《中华中医药学刊》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115671244A (en) * | 2022-12-02 | 2023-02-03 | 吴智勇 | A Chinese medicinal composition for treating prostatitis and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN103520461B (en) | Medicine for treating allergic rhinitis | |
| CN112138054A (en) | Chinese herbal medicine preparation for treating hemorrhoids and preparation method thereof | |
| CN101020015B (en) | Externally applied medicine for treating chronic prostatitis and prostatic hyperplasia | |
| CN112843200A (en) | A Chinese medicinal composition for treating prostatitis and its preparation method | |
| CN102772699B (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
| CN103768358B (en) | A kind of Chinese medicine composition for the treatment of chronic prostatitis | |
| CN103100003B (en) | Traditional Chinese medicine composition for treating acute gouty arthritis | |
| CN104940484A (en) | Traditional Chinese medicine for treating gout | |
| CN106552217A (en) | A kind of dendrobium wine and preparation method of conditioning prostatosis | |
| CN105796744A (en) | Toxin-removal traditional Chinese medicine ointment | |
| CN110812463A (en) | Traditional Chinese medicine enema for treating pelvic inflammation and preparation method thereof | |
| CN104547795A (en) | Traditional Chinese medicine preparation for treating chronic prostatitis | |
| CN104523911A (en) | Medicine for treating acute and chronic rhinitis | |
| CN114191528B (en) | Traditional Chinese medicine composition for treating cholelithiasis and preparation method and application thereof | |
| CN102824573B (en) | Medicine for treating prostatic diseases | |
| CN105412698A (en) | Traditional Chinese medicine composition for treating chronic prostatitis and preparation process thereof | |
| CN106619762A (en) | Traditional Chinese medicine preparation for treating benign prostatic hyperplasia | |
| CN106491843B (en) | A kind of Chinese medicine for treating cholecystolithiasis, kidney stone, vesical calculus | |
| CN106236904A (en) | A kind of Chinese medicine treating cystic polyp | |
| CN104645068A (en) | Enema for treatment of radiation proctitis | |
| CN105125805A (en) | Traditional Chinese medicine for curing cystolith | |
| CN104706971A (en) | Medicinal liquid for enema treatment of cervical cancer radiation proctitis | |
| CN105434808A (en) | Traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof | |
| CN104940356A (en) | Traditional Chinese medicine composition for treating uroschesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210528 |
|
| RJ01 | Rejection of invention patent application after publication |